Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Critical role of filamin-binding LIM protein 1 (FBLP-1)/migfilin in regulation of bone remodeling.

Xiao G, Cheng H, Cao H, Chen K, Tu Y, Yu S, Jiao H, Yang S, Im HJ, Chen D, Chen J, Wu C.

J Biol Chem. 2012 Jun 15;287(25):21450-60. doi: 10.1074/jbc.M111.331249. Epub 2012 May 3.

2.

Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.

Choudhary S, Blackwell K, Voznesensky O, Deb Roy A, Pilbeam C.

Bone. 2013 Sep;56(1):31-41. doi: 10.1016/j.bone.2013.04.017. Epub 2013 Apr 29.

3.

Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling.

Koskinen C, Persson E, Baldock P, Stenberg Å, Boström I, Matozaki T, Oldenborg PA, Lundberg P.

J Biol Chem. 2013 Oct 11;288(41):29333-44. doi: 10.1074/jbc.M113.494591. Epub 2013 Aug 29.

4.
5.

CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.

Kim JY, Min JY, Baek JM, Ahn SJ, Jun HY, Yoon KH, Choi MK, Lee MS, Oh J.

Bone. 2015 Oct;79:242-51. doi: 10.1016/j.bone.2015.06.011. Epub 2015 Jun 21.

PMID:
26103094
6.

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.

Bone. 1999 Nov;25(5):517-23.

PMID:
10574571
8.

Wnt5a/Ror2 mediates temporomandibular joint subchondral bone remodeling.

Yang T, Zhang J, Cao Y, Zhang M, Jing L, Jiao K, Yu S, Chang W, Chen D, Wang M.

J Dent Res. 2015 Jun;94(6):803-12. doi: 10.1177/0022034515576051. Epub 2015 Mar 6.

PMID:
25749876
9.

Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2.

Nishida S, Tsubaki M, Hoshino M, Namimatsu A, Uji H, Yoshioka S, Tanimori Y, Yanae M, Iwaki M, Irimajiri K.

Biochem Biophys Res Commun. 2005 Mar 4;328(1):91-7.

PMID:
15670755
10.

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T.

Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3597-602.

11.

IL-1 plays an important role in the bone metabolism under physiological conditions.

Lee YM, Fujikado N, Manaka H, Yasuda H, Iwakura Y.

Int Immunol. 2010 Oct;22(10):805-16. doi: 10.1093/intimm/dxq431. Epub 2010 Aug 2.

PMID:
20679512
12.

Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.

Mukherjee A, Rotwein P.

Mol Cell Biol. 2012 Jan;32(2):490-500. doi: 10.1128/MCB.06361-11. Epub 2011 Nov 7.

13.

Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.

Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC.

J Cell Physiol. 2005 Jun;203(3):573-82.

PMID:
15573398
14.

Inhibition of Ca²⁺/calmodulin-dependent protein kinase kinase 2 stimulates osteoblast formation and inhibits osteoclast differentiation.

Cary RL, Waddell S, Racioppi L, Long F, Novack DV, Voor MJ, Sankar U.

J Bone Miner Res. 2013 Jul;28(7):1599-610. doi: 10.1002/jbmr.1890.

15.

Annexin II stimulates RANKL expression through MAPK.

Li F, Chung H, Reddy SV, Lu G, Kurihara N, Zhao AZ, Roodman GD.

J Bone Miner Res. 2005 Jul;20(7):1161-7. Epub 2005 Feb 14.

16.

Basic fibroblast growth factor-induced neuronal differentiation of mouse bone marrow stromal cells requires FGFR-1, MAPK/ERK, and transcription factor AP-1.

Yang H, Xia Y, Lu SQ, Soong TW, Feng ZW.

J Biol Chem. 2008 Feb 29;283(9):5287-95. doi: 10.1074/jbc.M706917200. Epub 2008 Jan 2.

17.

Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling.

Kim HJ, Minashima T, McCarthy EF, Winkles JA, Kirsch T.

J Bone Miner Res. 2010 Aug;25(8):1771-83. doi: 10.1002/jbmr.60.

18.

Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis.

Leung R, Wang Y, Cuddy K, Sun C, Magalhaes J, Grynpas M, Glogauer M.

J Bone Miner Res. 2010 May;25(5):1077-91. doi: 10.1359/jbmr.091114.

19.

BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.

Valverde P, Tu Q, Chen J.

J Bone Miner Res. 2005 Sep;20(9):1669-79. Epub 2005 May 16.

20.

TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation.

Mahoney DJ, Mikecz K, Ali T, Mabilleau G, Benayahu D, Plaas A, Milner CM, Day AJ, Sabokbar A.

J Biol Chem. 2008 Sep 19;283(38):25952-62. doi: 10.1074/jbc.M802138200. Epub 2008 Jun 26.

Supplemental Content

Support Center